BioRegen
Third-party analytical testing provider with a client portal, public COA verification search, and stated peptide-testing intake on its official site.
This label reflects how the provider presents itself on its own site today, not a formal accreditation category.
Whether the site appears to invite direct sample submission from individuals rather than only business or institutional clients.
Whether the provider appears to offer public-facing report publishing, result browsing, or direct verification tooling.
This is our shorthand for how visible the provider's result or verification layer appears to be, ranging from none to searchable public verification.
Location details are kept conservative and only shown when clearly supported by the source page or the provider’s public materials.
What we can verify now
BioRegen publicly presents peptide testing as part of a broader third-party analytical-testing offering for supplements, nootropics, and research chemicals.
The official site publicly shows:
- a
Client Portal - a visible COA verification search flow
- a
New Customer Form - and peptide testing listed among the intake options
That is enough to support a live profile with both direct-submission and public-verification signals.
Coverage notes
- Public pricing is not clearly visible from the official site, so that remains
No - The strongest current peptide-specific cross-link is Peptide Partners’ public certification archive, which includes older BioRegen-issued files in its downloadable record set
Why it matters in the current ecosystem
BioRegen matters because it combines a real provider-side verification surface with a more conventional analytical-lab presentation.
That makes it useful as a middle-case provider in the directory:
- stronger than a quote-only lab page
- but less dominant in the current public vendor graph than Janoshik, TrustPointe, or Freedom Diagnostics
Its visible client-portal and verification tooling also make it a good reference point for readers who want something more open than a pure vendor-hosted PDF trail.
What to watch for
The main limitation is network density.
BioRegen is real enough to deserve a live profile, but its peptide-specific public cross-links are still thinner than the strongest current provider anchors. Readers should treat it as a credible searchable-verification provider, while recognizing that it does not yet recur across the vendor ecosystem as heavily as the top testing nodes.